Sanofi Stock Screener | Share Price & Fundamental Analysis
SANOFI
Pharmaceuticals
Share Price NSE
₹3381.50
▲
41.80 (1.25%)
Share Price BSE
₹3373.70
▲
24.30 (0.73%)
Track Sanofi share price live with TickJournal's free stock screener.
Analyze Sanofi share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Sanofi Market Cap
₹7,519.50 Cr.
SANOFI P/E Ratio (TTM)
18.96
Sanofi P/B Ratio
8.73
EPS (TTM)
₹179.46
Dividend Yield
3.58%
Debt to Equity
0.02
SANOFI 52 Week High
₹6569.50
Sanofi 52 Week Low
₹3190.90
Operating Margin
32.00%
Profit Margin
22.26%
SANOFI Revenue (TTM)
₹539.00
EBITDA
₹175.00
Net Income
₹120.00
Total Assets
₹1,612.00
Total Equity
₹861.00
Sanofi Share Price History - Stock Screener Chart
Screen SANOFI historical share price movements with interactive charts. Analyze price trends and patterns.
Sanofi Company Profile - Fundamental Screener
Screen Sanofi company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SANOFI shares.
Sanofi India Limited is a pharmaceutical company primarily engaged in manufacturing and trading drugs and pharmaceuticals. It operates manufacturing facilities in Goa and Ankleshwar, Gujarat, and sells products through independent distributors mainly in India. The company focuses on five therapeutic areas: diabetes, epilepsy, cardiology, allergy, and pain care. Key products...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
Aditya Narayan
ISIN
INE058A01010
Website
https://www.sanofiindialtd.com
Sanofi Balance Sheet Screener
Screen SANOFI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2024 | 2023 |
|---|---|---|
| Assets | ||
| Total Assets | 1,612 | 1,715 |
| Current Assets | 1,127 | 1,248 |
| Fixed Assets | 313 | 315 |
| Liabilities | ||
| Total Liabilities | 0 | 0 |
| Current Liabilities | 32 | 48 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 861 | 1,015 |
| Share Capital | 23 | 23 |
| Reserves & Surplus | 838 | 992 |
Sanofi Income Statement Screener - Profit & Revenue Analysis
Screen Sanofi income statement and profit fundamentals.
Analyze SANOFI quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Sanofi share price evaluation.
| Item | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 539 | 529 | 526 | 503 | 579 | 547 | 573 | 572 | 622 |
| Expenses | 364 | 397 | 404 | 367 | 400 | 370 | 377 | 393 | 368 |
| EBITDA | 175 | 132 | 122 | 137 | 179 | 177 | 195 | 179 | 254 |
| Operating Profit % | 32.00% | 23.00% | 23.00% | 21.00% | 22.00% | 21.00% | 23.00% | 24.00% | 29.00% |
| Depreciation | 10 | 10 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Profit Before Tax | 165 | 122 | 113 | 127 | 169 | 167 | 186 | 169 | 244 |
| Tax | 46 | 31 | 30 | 24 | 33 | 30 | 34 | 46 | 54 |
| Net Profit | 120 | 91 | 82 | 103 | 137 | 138 | 152 | 123 | 190 |
| EPS | 51.89 | 39.64 | 35.69 | 44.81 | 59.31 | 59.79 | 65.95 | 53.37 | 82.78 |
Sanofi Cash Flow Screener - Liquidity Fundamentals
Screen SANOFI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2024-March | 2023-March |
|---|---|---|
| Operating Activities | 462 | 230 |
| Investing Activities | -180 | 38 |
| Financing Activities | -392 | -878 |
| Net Cash Flow | -111 | -610 |
Sanofi Shareholding Pattern Screener
See Sanofi shareholding pattern with promoter, FII, and DII holdings.
Check Sanofi promoter holding and ownership changes for SANOFI on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 60.40% | 60.40% | 60.40% | 60.40% | 60.40% | 60.40% | 60.40% | 60.40% |
| FII Holding | 5.57% | 5.61% | 5.57% | 5.55% | 6.11% | 5.81% | 5.78% | 5.63% |
| DII Holding | 23.02% | 23.06% | 22.29% | 21.31% | 23.08% | 22.79% | 22.82% | 22.93% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 8.38% | 8.33% | 9.08% | 10.02% | 7.97% | 8.31% | 8.21% | 8.33% |
| Other Holding | 2.63% | 2.61% | 2.67% | 2.73% | 2.44% | 2.69% | 2.79% | 2.70% |
| Shareholder Count | 68,196 | 66,790 | 71,395 | 75,813 | 61,849 | 67,662 | 66,211 | 66,401 |
Sanofi Share Dividend Screener - Share Yield Analysis
Check Sanofi dividend history with payout and yield data.
View Sanofi dividend details including ex-dates and amounts for SANOFI stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹117.00 | 2.04% |
| 2023-March | ₹167.00 | 2.06% |
| 2022-March | ₹570.00 | 10.15% |
| 2021-March | ₹490.00 | 6.53% |
| 2020-March | ₹365.00 | 4.63% |
| 2019-March | ₹349.00 | 5.58% |
| 2018-March | ₹84.00 | 1.44% |
| 2017-March | ₹71.00 | 1.37% |
Sanofi Stock Index Membership
See which indices include Sanofi stock.
Check SANOFI index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
Sanofi Market Events Screener - Corporate Actions
Get Sanofi corporate actions including splits, bonuses, and buybacks.
Check Sanofi stock events that may affect SANOFI share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-02-25 | 2026-02-25 | Quarterly Result Announcement | NA | 1.74% |
| 2025-11-07 | 2025-11-07 | Dividend | ₹ 75.00 /share | -0.03% |
| 2025-10-29 | 2025-10-29 | Quarterly Result Announcement | NA | -0.56% |
| 2025-07-31 | 2025-07-31 | Quarterly Result Announcement | NA | -1.24% |
| 2025-05-15 | 2025-05-15 | Annual General Meeting | NA | 8.52% |
| 2025-05-14 | 2025-05-14 | Quarterly Result Announcement | NA | 3.02% |
| 2025-04-25 | 2025-04-25 | Dividend | ₹ 117.00 /share | 29.86% |
| 2025-02-27 | 2025-02-27 | Quarterly Result Announcement | NA | -5.58% |
| 2024-11-07 | 2024-11-07 | Quarterly Result Announcement | NA | -6.28% |
| 2024-05-14 | 2024-05-14 | Annual General Meeting | NA | -13.18% |
| 2024-05-03 | 2024-05-03 | Dividend | ₹ 117.00 /share | -5.75% |
| 2024-03-07 | 2024-03-07 | Dividend | ₹ 50.00 /share | -7.37% |
| 2023-12-18 | 2023-12-18 | Extraordinary General Meeting | NA | 3.21% |
| 2023-05-11 | 2023-05-11 | Annual General Meeting | NA | 5.58% |
| 2023-04-28 | 2023-04-29 | Dividend | ₹ 183.00 /share | 3.20% |
Sanofi Competitors Screener - Peer Comparison
Screen SANOFI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 406,351 | 37.86 | 54,729 | 9.71% | 10,980 | 37.98 |
| Divis Laboratories | 155,472 | 63.26 | 9,712 | 18.67% | 2,191 | 33.24 |
| Torrent Pharmaceuticals | 134,945 | 61.20 | 11,539 | 6.99% | 1,911 | 32.75 |
| Lupin | 103,954 | 22.26 | 22,910 | 13.74% | 3,306 | 47.35 |
| Dr Reddys Laboratories | 101,601 | 18.27 | 33,741 | 16.73% | 5,725 | 39.36 |
| Cipla | 96,320 | 21.31 | 28,410 | 7.12% | 5,291 | 26.86 |
| Zydus Life Science | 86,964 | 17.29 | 23,511 | 18.55% | 4,615 | 41.42 |
| Mankind Pharma | 82,499 | 45.81 | 12,744 | 20.90% | 2,007 | 41.40 |
| Aurobindo Pharma | 77,462 | 22.37 | 32,346 | 9.43% | 3,484 | 64.38 |
| Alkem Laboratories | 62,867 | 25.87 | 13,458 | 3.70% | 2,216 | 42.54 |
Sanofi Company Announcements - News Screener
Screen SANOFI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| Announcement under Regulation 30 (LODR)-Newspaper Publication | - | |
| 2026-04-07 | Communication Of Tax Deduction At Source On Final Dividend For The Financial Year Ended December 31 2025 | - |
| 2026-04-07 | Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (The Listing Regulations) | - |
| 2026-04-07 | Intimation Regarding Receipt Of Central Government Approval For Appointment Of The Managing Director Of The Company | - |
| 2026-04-07 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-04-07 | Notice Of 70Th Annual General Meeting Of The Company | - |
| 2026-04-07 | Reg. 34 (1) Annual Report. | - |
| 2026-04-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-04-02 | Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-03-30 | Intimation Of Book Closure | - |
| 2026-03-30 | Record Date For Final Dividend For The Financial Year Ended 31St December 2025 | - |
| 2026-03-30 | Convening Of The Seventieth Annual General Meeting Of The Company | - |
| 2026-03-29 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-03-29 | Closure of Trading Window | - |
| 2026-03-29 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-03-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-03-05 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-02-27 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-02-26 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-02-26 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |